Our diagnostic time for lung cancer

F. Guldaval, G. Balci, N. Kurtul, H. Isguder, R. Ozacar (Izmir, Turkey)

Source: Annual Congress 2005 - Epidemiology and evaluation of lung cancer patients - quality of life
Session: Epidemiology and evaluation of lung cancer patients - quality of life
Session type: Thematic Poster Session
Number: 2123
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Guldaval, G. Balci, N. Kurtul, H. Isguder, R. Ozacar (Izmir, Turkey). Our diagnostic time for lung cancer. Eur Respir J 2005; 26: Suppl. 49, 2123

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


An algorithm for lung cancer staging
Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer
Year: 2014


Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008


Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007

Diagnostic delay time of lung cancer in a community study
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008

Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Delays in diagnosis of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 298s
Year: 2004

EUS-NA in lung cancer
Source: Annual Congress 2008 - Endoscopic needle techniques
Year: 2008


The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: 915-919
Year: 2006



Delays in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



Screening and diagnosis of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010